About hearX®
We don't just set industry standards; we redefine them
hearX is a vision-led, value-driven company at the forefront of revolutionizing audiological assessments and access to hearing healthcare.
Since our inception in 2016, we have remained committed to continuous innovation that stands as a beacon of transformative technologies which shape the hearing healthcare landscape.
Our portable, user-friendly screening and diagnostic products enable healthcare professionals to conduct accurate and clinically-validated hearing assessments on the go.
Our Values
People first
Quality innovation
Trust
As a key player in the audiological tech industry, we consistently set new benchmarks, offering unmatched value to audiologists, pharmaceutical companies, research organizations and businesses.
Our clients
Awards
Projects and partners
hearWHO
Mobile app for hearing screening
Based on validated digits-in-noise technology, the hearWHO app was developed solely by hearX Group. It provides the general public access to a hearing screener to check their hearing status and monitor it over time. Screening languages include English, Mandarin and Spanish.
More than 263,800 app installs since its launch.
Höra
Mobile app to test, monitor and preserve hearing
In December 2019, the Fondation Pour l'Audition in France launched Höra, a mobile application for identifying hearing loss in only 3 minutes. The digits-in-noise test technology, developed by hearX Group, enables users to pre-screen for potential hearing loss. The French digit material in this product is owned by the Fondation Pour l'Audition and was recorded in collaboration with the University of Montpellier.
Meet our Board of Directors
Prof De Wet Swanepoel
Professor of Audiology, University of Pretoria Editor-in-chief, International Journal of Audiology
Nic Klopper
CEO at hearX Group
Albert Lotter
Managing Director at Noise Clipper
Anders Kronborg
CEO at ResoTher Pharma
Jordan Bernstein
Managing Director and General Counsel of CI Capital Partners, a New York based private investment firm
Frederick Iseman
Chairman and CEO of CI Capital Partners, a New York based private investment firm
Jeremy Lim, MD
Health technology advisor, Agency for Science, Technology and Research (ASTAR), Singapore and Co-Director, Global Health, National University of Singapore Saw Swee Hock School of Public Health